A Mutation in the Beta-myosin Rod Associated with Hypertrophic Cardiomyopathy Has an Unexpected Molecular Phenotype

Overview

Journal Biochem Biophys Res Commun

Publisher Elsevier

Specialty Biochemistry

Date 2009 Nov 17

PMID 19913502

Citations 7

Authors

Thomas Z Armel

Leslie A Leinwand

Affiliations

Soon will be listed here.

Abstract

Hypertrophic cardiomyopathy (HCM) is a common, autosomal dominant disorder primarily characterized by left ventricular hypertrophy and is the leading cause of sudden cardiac death in youth. HCM is caused by mutations in several sarcomeric proteins, with mutations in MYH7, encoding beta-MyHC, being the most common. While many mutations in the globular head region of the protein have been reported and studied, analysis of HCM-causing mutations in the beta-MyHC rod domain has not yet been reported. To address this question, we performed an array of biochemical and biophysical assays to determine how the HCM-causing E1356K mutation affects the structure, stability, and function of the beta-MyHC rod. Surprisingly, the E1356K mutation appears to thermodynamically destabilize the protein, rather than alter the charge profile know to be essential for muscle filament assembly. This thermodynamic instability appears to be responsible for the decreased ability of the protein to form filaments and may be responsible for the HCM phenotype seen in patients.

Citing Articles

Cardiac sarcomere mechanics in health and disease.

Crocini C, Gotthardt M Biophys Rev. 2021; 13(5):637-652.

PMID: 34745372 PMC: 8553709. DOI: 10.1007/s12551-021-00840-7.

Secondary Structure of the Novel Myosin Binding Domain WYR and Implications within Myosin Structure.

Menard L, Wood N, Vigoreaux J Biology (Basel). 2021; 10(7).

PMID: 34209926 PMC: 8301185. DOI: 10.3390/biology10070603.

A1603P and K1617del, Mutations in β-Cardiac Myosin Heavy Chain that Cause Laing Early-Onset Distal Myopathy, Affect Secondary Structure and Filament Formation In Vitro and In Vivo.

Parker F, Batchelor M, Wolny M, Hughes R, Knight P, Peckham M J Mol Biol. 2018; 430(10):1459-1478.

PMID: 29660325 PMC: 5958240. DOI: 10.1016/j.jmb.2018.04.006.

Myosin storage myopathy mutations yield defective myosin filament assembly in vitro and disrupted myofibrillar structure and function in vivo.

Viswanathan M, Tham R, Kronert W, Sarsoza F, Trujillo A, Cammarato A Hum Mol Genet. 2017; 26(24):4799-4813.

PMID: 28973424 PMC: 5886249. DOI: 10.1093/hmg/ddx359.

Myosin Storage Myopathy in C. elegans and Human Cultured Muscle Cells.

Dahl-Halvarsson M, Pokrzywa M, Rauthan M, Pilon M, Tajsharghi H PLoS One. 2017; 12(1):e0170613.

PMID: 28125727 PMC: 5268365. DOI: 10.1371/journal.pone.0170613.

References

Buvoli M, Hamady M, Leinwand L, Knight R . Bioinformatics assessment of beta-myosin mutations reveals myosin's high sensitivity to mutations. Trends Cardiovasc Med. 2008; 18(4):141-9. PMC: 2587080. DOI: 10.1016/j.tcm.2008.04.001. View

Greenfield N . Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions. Nat Protoc. 2007; 1(6):2527-35. PMC: 2752288. DOI: 10.1038/nprot.2006.204. View

Van Driest S, Jaeger M, Ommen S, Will M, Gersh B, Tajik A . Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004; 44(3):602-10. DOI: 10.1016/j.jacc.2004.04.039. View

Burch M, Blair E . The inheritance of hypertrophic cardiomyopathy. Pediatr Cardiol. 1999; 20(5):313-6. DOI: 10.1007/s002469900475. View

Maron B, Gardin J, Flack J, Gidding S, Kurosaki T, Bild D . Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995; 92(4):785-9. DOI: 10.1161/01.cir.92.4.785. View

Flashman E, Watkins H, Redwood C . Localization of the binding site of the C-terminal domain of cardiac myosin-binding protein-C on the myosin rod. Biochem J. 2006; 401(1):97-102. PMC: 1698665. DOI: 10.1042/BJ20060500. View

Greenfield N . Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc. 2007; 1(6):2876-90. PMC: 2728378. DOI: 10.1038/nprot.2006.202. View

Maron B, Carney K, Lever H, Lewis J, Barac I, Casey S . Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003; 41(6):974-80. DOI: 10.1016/s0735-1097(02)02976-5. View

Obermann W, van der Ven P, Steiner F, Weber K, Furst D . Mapping of a myosin-binding domain and a regulatory phosphorylation site in M-protein, a structural protein of the sarcomeric M band. Mol Biol Cell. 1998; 9(4):829-40. PMC: 25310. DOI: 10.1091/mbc.9.4.829. View

10.

Armel T, Leinwand L . Mutations at the same amino acid in myosin that cause either skeletal or cardiac myopathy have distinct molecular phenotypes. J Mol Cell Cardiol. 2009; 48(5):1007-13. PMC: 2854248. DOI: 10.1016/j.yjmcc.2009.10.011. View

11.

Maron B . Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002; 287(10):1308-20. DOI: 10.1001/jama.287.10.1308. View

12.

Welikson R, Fischman D . The C-terminal IgI domains of myosin-binding proteins C and H (MyBP-C and MyBP-H) are both necessary and sufficient for the intracellular crosslinking of sarcomeric myosin in transfected non-muscle cells. J Cell Sci. 2002; 115(Pt 17):3517-26. DOI: 10.1242/jcs.115.17.3517. View

13.

Roberts R, Sigwart U . New concepts in hypertrophic cardiomyopathies, part I. Circulation. 2001; 104(17):2113-6. DOI: 10.1161/hc4201.097429. View

14.

Armel T, Leinwand L . Mutations in the beta-myosin rod cause myosin storage myopathy via multiple mechanisms. Proc Natl Acad Sci U S A. 2009; 106(15):6291-6. PMC: 2669361. DOI: 10.1073/pnas.0900107106. View